On December 14, 2022, Medifron DBT Co., Ltd. closed the transaction. The company issued 3,427,600 shares in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,241 KRW | +0.98% | -5.56% | -25.82% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,452 KRW | -2.75% | +1.26% | 88.16M | ||
1,241 KRW | +0.98% | -5.56% | 63.94M | ||
1st Jan change | Capi. | |
---|---|---|
-25.82% | 63.94M | |
-19.11% | 177B | |
-2.39% | 159B | |
+1.41% | 153B | |
+4.72% | 100B | |
+10.51% | 81.1B | |
+23.57% | 75.87B | |
-8.88% | 69.81B | |
-30.63% | 45.59B | |
-10.34% | 42.96B |
- Stock Market
- Equities
- A057680 Stock
- News T Scientific Co.,Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd